Author | Alberto Montero, MD | OncLive

Author | Alberto Montero, MD


Dr. Montero Discusses PERTAIN Study in HER2-Positive Breast Cancer

January 09, 2017


Alberto J. Montero, MD, Department of Hematology and Oncology at Cleveland Clinic, discusses the PERTAIN study in postmenopausal women with hormone receptor-positive, HER2-positive, locally advanced or metastatic breast cancer. The study looks at the impact of adding pertuzumab (Perjeta) to trastuzumab (Herceptin) in aromatase inhibitor (AI) therapy.

Dr. Alberto Montero on Reducing Readmission Rates for Oncology Patients

September 02, 2015


Alberto Montero, MD Staff Physician in the Department of Solid Tumor Oncology, Cleveland Clinic, discusses reducing readmission rates for oncology patients.